1-3 of 3
Sushanth Gouni
Close
Sort by
Journal Articles

SIRPα + macrophages are increased in patients with FL who progress or relapse after frontline lenalidomide and rituximab

Mario L. Marques-Piubelli, Edwin R. Parra, Lei Feng, Luisa Solis Soto, Mariana Gallardo, Sushanth Gouni, Felipe Samaniego, Mansoor Noorani, Fredrick B. Hagemeister, Jason R. Westin, Hun Ju Lee, Maria A. Rodriguez, Sattva S. Neelapu, Jillian R. Gunther, Nathan H. Fowler, Christopher R. Flowers, Ignacio I. Wistuba, Loretta J. Nastoupil, Francisco Vega, Paolo Strati
Journal: Blood Advances
Blood Adv (2022) 6 (11): 3286–3293.
https://doi.org/10.1182/bloodadvances.2022007104
Published: 2022
Includes: Supplemental data
Journal Articles

A multicenter retrospective study of polatuzumab vedotin in patients with large B-cell lymphoma after CAR T-cell therapy

Sushanth Gouni, Allison C. Rosenthal, Jennifer L. Crombie, Andrew Ip, Manali K. Kamdar, Brian Hess, Lei Feng, Grace Watson, Amy Ayers, Sattva S. Neelapu, Arushi Khurana, Yi Lin, Madiha Iqbal, Reid W. Merryman, Paolo Strati
Journal: Blood Advances
Blood Adv (2022) 6 (9): 2757–2762.
https://doi.org/10.1182/bloodadvances.2021006801
Published: 2022
Journal Articles

Follicular lymphoma and macrophages: impact of approved and novel therapies

Sushanth Gouni, Mario L. Marques-Piubelli, Paolo Strati
Journal: Blood Advances
Blood Adv (2021) 5 (20): 4303–4312.
https://doi.org/10.1182/bloodadvances.2021005722
Published: 2021